Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that it has acquired Logos Technologies (“Logos”) representing its strategic move into the early phase clinical trials market. ... read more

EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, today accepted the Chairman’s Award from Governor Deval Patrick at the Associated Industries of Massachusetts (AIM) Annual Meeting held in Waltham, MA. This award recognizes a Massachusetts firm, ... read more

Mirna Therapeutics, Inc., a biotechnology company pioneering microRNA (miRNA) replacement therapies for cancer, announced today that it has initiated a Phase 1 clinical study of MRX34, the first miRNA to advance into a human clinical trial for cancer. The Phase 1 trial is being conducted in ... read more

Harris Corporation (NYSE:HRS), an international communications and information technology company, has been awarded a $45 million contract to support Department of Homeland Security (DHS) Immigration and Customs Enforcement (ICE) tactical communications networks. Harris will team with Computer Sciences Corporation ... read more

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an overview of the Company's business strategy and commercial and development-stage programs will be given at the UBS Global Healthcare ... read more

Sucampo Pharmaceuticals, Inc. (“Sucampo”) (NASDAQ: SCMP), a global pharmaceutical company, today announced that it will host a meeting to discuss the recent opioid-induced constipation (OIC) indication approval for its flagship product, AMITIZA, on May 20, 2013, from 9:00 to 10:30AM ET in Orlando, FL. Members of ... read more

Elan Corporation, plc (NYSE: ELN) (Elan) provides additional commentary on today’s royalty participation agreement announcement between Elan and Theravance. As announced, Elan will make a one-time cash payment of $1.0 billion to Theravance in exchange for a 21% participation interest in the potential future royalty payments ... read more

For the first time since measurements began in 1958 by acclaimed researcher Dr. Charles David Keeling of the Scripps Institution of Oceanography, UC San Diego, the concentration of carbon dioxide (CO2) at Hawaii’s Mauna Loa Observatory surpassed 400 parts per million (ppm) this week. In collaboration ... read more

Nanostim, Inc., a privately-owned developer of miniaturized, leadless cardiac pacemakers (LCP), today announced preliminary results from its LEADLESS study during the late breaking clinical trial presentations at Heart Rhythm 2013, the Heart Rhythm Society’s 34th Annual Scientific Sessions in Denver. Early findings from the study of ... read more

Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will present at the Bank of America Merrill Lynch Health Care Conference on Thursday, May 16, at 8:00 a.m. Pacific Standard Time. The conference will be held at the Encore at Wynn Las Vegas, Las Vegas, ... read more

Researchers at the U.S. Naval Research Laboratory flew their fuel cell powered Ion Tiger unmanned aerial vehicle (UAV) for 48 hours and 1 minute, April 16 to 18, by using liquid hydrogen (LH2) fuel in a new, NRL-developed, cryogenic fuel storage tank and delivery system. This ... read more

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced financial and operating results for the first quarter ended March 31, 2013 and other business updates. Total product revenue was $202.6 million for the first quarter of 2013, an 18% increase compared to ... read more

Advanced Cell Technology, Inc. (“ACT” or the ”Company”; OTCBB: ACTC) a leader in the field of regenerative medicine, announced today its first quarter financial results for the period ended March 31, 2013. The Company reported a loss from operations of $(5.8) million compared to a loss ... read more

Waters Corporation (NYSE:WAT) John Ornell, Chief Financial Officer, will speak to the investment community at the Bank of America Merrill Lynch 2013 Health Care Conference at the Encore at the Wynn, in Las Vegas, on Tuesday, May 14th, at 10:00 a.m. pacific time. ... read more

The number of Sacramento region med tech companies now totals 126, an increase of 10 percent compared to last year, according to a report released today by the Sacramento Regional Technology Alliance (SARTA). The SARTA 2013 MedStart Progress Report ... read more

Bayer, as part of its year-long celebration of the company’s 150th anniversary, has built an airship to tour the world as an international ambassador. The Bayer Airship will visit the United States on May 16-23, making stops in New York and New Jersey. ... read more

T2 Biosystems, a company developing direct detection products enabling superior diagnostics, has been awarded the 2013 Rising Star Award by the Smaller Business Association of New England (SBANE). The SBANE New England Innovation Award recipients are chosen from a field of over 200 nominees and represent ... read more

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that executives from BioCryst are scheduled to present and provide a corporate summary and update regarding the Company’s clinical programs at the following investor conferences: ... read more

Comprehend Systems was named one of only five Gartner “Cool Vendors in Life Sciences, 2013” for its ability to offer clinical research sponsors unparalleled access to clinical and operational data insights. Compiled by leading Gartner analysts including Steven Lefebure, Dale ... read more

Industry Standard Research (ISR) released a new market research report today entitled “Risk-based Monitoring: Industry Guidance on Adoption, Use, and Outsourcing.” The report was developed by surveying industry professionals with direct risk-based monitoring (RBM) experience and provides the pharmaceutical ... read more